Delivery effectiveness of and adherence to intermittent preventive treatment for malaria in pregnancy with dihydroartemisinin–piperaquine with or without targeted information transfer or sulfadoxine–pyrimethamine in western Kenya: a three-armed, prag
European and Developing Countries Clinical Trials Partnership 2, UK Joint Global Health Trials Scheme of the Foreign, Commonwealth and Development Office, Medical Research Council, National Institute for Health and Care Research, and Wellcome Trust; and Swedish International Development Cooperation Agency.
Authors
- Miriam Taegtmeyer (ORCID: https://orcid.org/0000-0002-5377-2536)
- Jayne Webster (ORCID: https://orcid.org/0000-0002-0498-8883)
- Feiko O. ter Kuile (ORCID: https://orcid.org/0000-0003-3663-5617)
- Alloys K’Oloo
- James Dodd (ORCID: https://orcid.org/0000-0003-4805-5759)
- Maia Lesosky (ORCID: https://orcid.org/0000-0002-2026-958X)
- Isdorah Odero (ORCID: https://orcid.org/0000-0002-1773-9325)
- Hellen C. Barsosio (ORCID: https://orcid.org/0000-0002-0261-9814)
- Frederick Omiti
- Michael A Ojuok
- Dawn Odiwa
- Simon Kariuki (ORCID: https://orcid.org/0000-0001-9241-5550)
- Benson Omondi
- Elizabeth Okello
Institutions
- Liverpool School of Tropical Medicine (GB)
- Kenya Medical Research Institute (KE)
- London School of Hygiene & Tropical Medicine (GB)
- Imperial College London (GB)
Publication Details
- Journal
- The Lancet Global Health
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1016/s2214-109x(24)00261-4
- Citations
- 5
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Styrelsen för Internationellt Utvecklingssamarbete
- Wellcome Trust
- Department of Health and Social Care
- Foreign, Commonwealth and Development Office
- Medical Research Council
- European and Developing Countries Clinical Trials Partnership